Fluconazole (all routes except local only) - Cumulative dose > 150 mg updated on 01-29-2025

Table   Graphic     exposition period:

Congenital malformations
Adverse outcome OR 95%CII2k No. casesNo. exposedpublication biasROBE-value
All congenital malformations (majors, minors, majors and minors, or unspecified)1.20 [0.99, 1.46]0%2 studies44,7503,670not evaluable ROB-
Limb defects1.18 [0.80, 1.75]0%2 studies12,4413,670not evaluable ROB-
Cleft lip with or without cleft palate1.26 [0.42, 3.77]-1 study1,2693,270not evaluable ROB-
Cleft palate1.69 [0.39, 7.30]-1 study5003,270not evaluable ROB-
Congenital heart defects1.06 [0.67, 1.68]-1 study7,8673,270not evaluable ROB-
Eye defects1.50 [0.37, 6.11]-1 study728400not evaluable ROB-
Genital anomalies2.30 [0.94, 5.62]-1 study1,179400not evaluable ROB-
Major congenital malformations1.20 [0.99, 1.46]0%2 studies44,7503,670not evaluable ROB-
Nervous system anomalies1.97 [0.72, 5.39]-1 study899400not evaluable ROB-
Tetralogy of Fallot3.20 [0.74, 13.82]-1 study2903,270not evaluable ROB-
Urinary malformations1.41 [0.62, 3.22]-1 study2,203400not evaluable ROB-
Ventricular septal defect1.55 [0.84, 2.86]-1 study3,1893,270not evaluable ROB-
Cardiac septal defects1.81 [1.04, 3.15]-1 study3,282400not evaluable ROB3.02 [1.25; .]
Craniosynostosis1.94 [0.65, 5.80]-1 study7213,270not evaluable ROB-
Digestive system anomalies1.95 [0.60, 6.33]-1 study625400not evaluable ROB-
Hypoplastic left heart (HLH/HLHS)2.33 [0.33, 16.58]-1 study2,252not evaluable ROB-
Polydactyly2.71 [1.01, 7.27]-1 study2,252not evaluable ROB4.86 [1.11; .]
Syndactyly0.62 [0.09, 4.34]-1 study2,252not evaluable ROB-

Neonatal disorders
Adverse outcome OR 95%CII2k No. casesNo. exposedpublication biasROBE-value
Neonatal death (< 28 days of life)0.66 [0.27, 1.61]-1 study1824,530not evaluable ROB-

Intrauterine deaths
Adverse outcome OR 95%CII2k No. casesNo. exposedpublication biasROBE-value
Early intrauterine deaths (< 22 weeks) / Spontaneous abortions2.42 [1.28, 4.56]73%3 studies30,0701,238not evaluable ROB4.27 [1.88; .]
Late intrauterine deaths (> 22 weeks) / Stillbirths1.31 [0.32, 5.34]85%3 studies1,1955,153not evaluable ROB-

Hide endpoints reported in only one study ...